Patent classifications
A23V2250/2108
Nutraceutical formulation for unblocking receptors
A nutraceutical formulation used to unblock receptors is disclosed herein. The nutraceutical formulation used to therapeutically treat humans includes arachidonic acid, docosahexaenoic acid (DHA), echinacea, kaempferol, coffee fruit, and probiotics.
Edible Energy Composition
An energy composition includes a methylated xanthine, a choline derivative, and at least one flavorant in a sufficient amount to render the energy composition palatable. The energy composition may also include vitamins, amino acids, preservatives, and the like.
Edible Energy Composition
An energy composition includes a methylated xanthine, a choline derivative, and at least one flavorant in a sufficient amount to render the energy composition palatable. The energy composition may also include vitamins, amino acids, preservatives, and the like.
HIGHLY CAFFEINATED COCOA-BASED COMPOSITION AND METHODS OF MAKING AND USING THEREOF
A highly caffeinated cocoa-based composition, comprising, a cocoa component comprising cocoa powder; a caffeinated component comprising caffeine, wherein the highly caffeinated cocoa-based composition comprises at least about 1% caffeine by weight; a fat component; a sweetening component, and a complexing component, wherein the complexing component is configured to reduce the bitterness of the caffeinated component, the cocoa component, or both.
HIGHLY CAFFEINATED COCOA-BASED COMPOSITION AND METHODS OF MAKING AND USING THEREOF
A highly caffeinated cocoa-based composition, comprising, a cocoa component comprising cocoa powder; a caffeinated component comprising caffeine, wherein the highly caffeinated cocoa-based composition comprises at least about 1% caffeine by weight; a fat component; a sweetening component, and a complexing component, wherein the complexing component is configured to reduce the bitterness of the caffeinated component, the cocoa component, or both.
DIETARY SUPPLEMENT COMPOSITION COMPRISING COLLAGEN
The present invention is directed to improving physical and athletic performance and supporting recovery of joints, ligaments, and tendons with collagen peptides and dietary ingredients that physical and athletic performance. The dietary supplement composition of the present invention comprise collagen, preferably in the form of hydrolyzed collagen peptides, in combination with Branched-Chain Amino Acids (BCAA), Creatine Nitrate, Arginine Nitrate, N- acetyl-L-Carnitine, L-Citrulline, Betaine Anhydrous, Alpha-Glyceryl Phosphoryl Choline, Ancient Peat Extract with Apple Fruit Extract, and Caffeine. Physical and athletic performance, as well as recovery from exercise, is improved using this combination of components.
DIETARY SUPPLEMENT COMPOSITION COMPRISING COLLAGEN
The present invention is directed to improving physical and athletic performance and supporting recovery of joints, ligaments, and tendons with collagen peptides and dietary ingredients that physical and athletic performance. The dietary supplement composition of the present invention comprise collagen, preferably in the form of hydrolyzed collagen peptides, in combination with Branched-Chain Amino Acids (BCAA), Creatine Nitrate, Arginine Nitrate, N- acetyl-L-Carnitine, L-Citrulline, Betaine Anhydrous, Alpha-Glyceryl Phosphoryl Choline, Ancient Peat Extract with Apple Fruit Extract, and Caffeine. Physical and athletic performance, as well as recovery from exercise, is improved using this combination of components.
DEUTERATED CAFFEINE AND USES THEREOF
Provided herein are compositions (e.g., pharmaceutical compositions, nutraceutical compositions, foods, beverages, cosmetic compositions, diet supplements) comprising deuterated caffeine. The provided compositions may be useful for treating and/or preventing various diseases and conditions, such as obesity, causing weight loss, increasing metabolic rate, reducing appetite, increasing energy expenditure, increasing urine output, increasing sodium excretion, reducing edema, a pain disorder, apnea, hypotension, an encephalopathy, a neurological or psychiatric disorder, and an inflammatory disorder.
Deuterated caffeine and uses thereof
Provided herein are compositions (e.g., pharmaceutical compositions, nutraceutical compositions, foods, beverages, cosmetic compositions, diet supplements) comprising deuterated caffeine. The provided compositions may be useful for treating and/or preventing various diseases and conditions, such as obesity, causing weight loss, increasing metabolic rate, reducing appetite, increasing energy expenditure, increasing urine output, increasing sodium excretion, reducing edema, a pain disorder, apnea, hypotension, an encephalopathy, a neurological or psychiatric disorder, and an inflammatory disorder.
Deuterated caffeine and uses thereof
Provided herein are compositions (e.g., pharmaceutical compositions, nutraceutical compositions, foods, beverages, cosmetic compositions, diet supplements) comprising deuterated caffeine. The provided compositions may be useful for treating and/or preventing various diseases and conditions, such as obesity, causing weight loss, increasing metabolic rate, reducing appetite, increasing energy expenditure, increasing urine output, increasing sodium excretion, reducing edema, a pain disorder, apnea, hypotension, an encephalopathy, a neurological or psychiatric disorder, and an inflammatory disorder.